Related Experiment Video
Updated: Jun 1, 2026
09:55
In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
Chemokines and BPH/LUTS.
1Department of Urology, The University of Michigan School of Medicine, 6217 Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0944, USA. jcoska@umich.edu
Differentiation; Research in Biological Diversity
|May 24, 2011
Summary
Chemokines secreted by the aging prostate promote cell over-proliferation, contributing to Benign Prostatic Hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Further research is needed to explore chemokines as therapeutic targets for BPH/LUTS.
Area of Science:
- Urology
- Cell Biology
- Molecular Biology
Background:
- Prostatic microenvironments secrete chemokines due to aging and inflammation.
- Senescent cells and chronic prostatitis may drive chemokine secretion.
- Chemokines act as growth factors, stimulating proliferation in prostate tissues.
Purpose of the Study:
- To investigate the role of chemokines in Benign Prostatic Hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
- To explore the signaling pathways involved in chemokine-mediated prostate cell proliferation.
- To assess the potential of chemokines as therapeutic targets for BPH/LUTS.
Main Methods:
- Review of published studies on prostatic chemokine secretion and function.
- Analysis of experimental evidence for chemokine-stimulated proliferation via MAPK and PI3K pathways.
- Examination of literature on chemokine-mediated angiogenesis in BPH.
Main Results:
- Chemokines stimulate prostate stromal and epithelial cell proliferation through MAPK and PI3K signaling.
- Chemokine-mediated angiogenesis may contribute to BPH/LUTS development.
- Low-level chemokine secretion in aging prostates leads to cumulative cell over-proliferation and increased volume.
Conclusions:
- Chemokines likely promote prostatic enlargement and associated lower urinary tract symptoms (LUTS).
- Chemokines are potential therapeutic targets for delaying or ablating BPH/LUTS.
- Further research is warranted to fully elucidate the role of chemokines in BPH.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:21Chemotaxis and Direction of Cell Migration
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.